1,014
Views
0
CrossRef citations to date
0
Altmetric
Reviews

Does the climacteric influence the prevalence, incidence and type of urinary incontinence?

ORCID Icon &
Pages 75-79 | Received 11 Nov 2022, Accepted 11 Dec 2022, Published online: 23 Jan 2023

References

  • Milsom I, Altman D, Cartwright R, et al. Epidemiology of urinary incontinence (UI) and other lower urinary tract symptoms (LUTS), pelvic organ prolapse (POP) and anal (AI) incontinence. In: Abrams P, Cardozo L, Wagg A, Wein A, editors. Incontinence. 6th ed. Paris: Health Publications Ltd; 2016. p. 17–24.
  • Irwin DE, Kopp ZS, Agatep B, et al. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int. 2011;108(7):1132–1138.
  • Ekelund P, Grimby A, Milsom I. Urinary incontinence: social and financial costs high. BMJ. 1993;306(6888):1344.
  • Wagner T, Moore K, Subak L, et al. Economics of urinary and faecal incontinence, and prolapse. In: Abrams P, Cardozo L, Wagg A, Wein A, editors. Incontinence. 6th ed. Paris: Health Publications Ltd; 2016. p. 17–24.
  • Hannestad YS, Rortveit G, Sandvik H, et al. A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. J Clin Epidemiol. 2000;53(11):1150–1157.
  • Milsom I, Ekelund P, Molander U, et al. The influence of age, parity, oral contraception, hysterectomy and menopause on the prevalence of urinary incontinence in women. J Urol. 1993;149(6):1459–1462.
  • Grodstein F, Fretts R, Lifford K, et al. Association of age, race, and obstetric history with urinary symptoms among women in the Nurses’ health study. Am J Obstet Gynecol. 2003;189(2):428–434.
  • Fantl JA, Cardozo L, McClish DK. Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the hormones and urogenital therapy committee. Obstet Gynecol. 1994;83(1):12–18.
  • Diokno AC, Brock BM, Herzog AR, et al. Medical correlates of urinary incontinence in the elderly. J Urol. 1990;36(2):129–138.
  • Thom DH, van den Eeden SK, Brown JS. Evaluation of parturition and other reproductive variables as risk factors for urinary incontinence in later life. Obstet Gynecol. 1997;90(6):983–989.
  • Grodstein F, Lifford K, Resnick NM, et al. Postmenopausal hormone therapy and risk of developing urinary incontinence. Obstet Gynecol. 2004;103(2):254–260.
  • Grady D, Brown JS, Vittinghoff E, et al. Postmenopausal hormones and incontinence: the heart and Estrogen/progestin replacement study. Obstet Gynecol. 2001;97(1):116–120.
  • Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4–20.
  • Hunskaar S, Lose G, Sykes D, et al. The prevalence of urinary incontinence in women in four european countries. BJU Int. 2004;93(3):324–330.
  • Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306–1314.
  • Coyne KS, Sexton CC, Thompson CL, et al. The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU Int. 2009;104(3):352–360.
  • Samuelsson E, Victor A, Tibblin G. A population study of urinary incontinence and nocturia among women 20–59 years. Prevalence, well-being and wish for treatment. Acta Obstet Gynecol Scand. 1997;76(1):74–80.
  • Simeonova Z, Milsom I, Kullendorff AM, et al. The prevalence of urinary incontinence and its influence on the quality of life in women from an urban Swedish population. Acta Obstet Gynecol Scand. 1999 Jul;78(6):546–551.
  • Wennberg A, Molander U, Fall M, et al. A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women. Eur Urol. 2009;55(4):783–791.
  • Malmsten UG, Molander U, Peeker R, et al. Urinary incontinence, overactive bladder, and other lower urinary tract symptoms: a longitudinal population-based survey in men aged 45–103 years. Eur Urol. 2010;58(1):149–156.
  • Thomas TM, Plymat KR, Blannin J, et al. Prevalence of urinary incontinence. Br Med J. 1980;281(6250):1243–1245.
  • Iosif S, Henriksson L, Ulmsten U. The frequency of disorders of the lower urinary tract, urinary incontinence in particular, as evaluated by a questionnaire survey in a gynecological health control population. Acta Obstet Gynecol Scand. 1981;60(1):71–76.
  • Jolleys J. Reported prevalence of urinary incontinence in women in a general practice. Br Med J. 1988;296(6632):1300–1302.
  • Townsend MK, Danforth KN, Lifford KL, et al. Incidence and remission of urinary incontinence in Middle-aged women. Am J Obstet Gynecol. 2007;197(2):167.e1–167.e5.
  • Waetjen LE, Ye J, Feng W-Y, et al. Association between menopausal transition stages and developing urinary incontinence. Obstet Gynecol. 2009;114(5):989–998.
  • Mishra GD, Cardozo L, Kuh D. Menopausal transition and the risk of urinary incontinence: results from a British prospective cohort. BJU Int. 2010;106(8):1170–1175.
  • Jahanlu D, Hunskaar S. The Hordaland women’s cohort: prevalence, incidence, and remission of urinary incontinence in middle-aged women. Int Urogynecol J. 2010;21(10):1223–1229.
  • Jahanlu D, Hunskaar S. Type and severity of new-onset urinary incontinence in middle-aged women: the Hordaland Women’s Cohort. Neurourol Urodyn. 2011;30(1):87–92.
  • Hägglund D, Walker-Engstrom ML, Larsson G, et al. Changes in urinary incontinence and quality of life after four years: a population-based study of women aged 22-50 years. Scand J Prim Health Care. 2004;22(2):112–117.
  • Samuelsson EC, Victor FT, Svardsudd KF. Five-year incidence and remission rates of female urinary incontinence in a Swedish population less than 65 years old. Am J Obstet Gynecol. 2000;183(3):568–574.
  • Diokno AC, Brock BM, Herzog AR, et al. Medical correlates of urinary incontinence in the elderly. Urology. 1990;36(2):129–138.
  • Cody JD, Richardson K, Moehrer B, et al. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev. 2012;10(10):CD001405. (Online) CD001405.
  • Hendrix SL, Cochrane BB, Nygaard IE, et al. Effects of estrogen with and without progestin on urinary incontinence. JAMA. 2005;293(8):935–948.
  • Du Beau CE. Estrogen treatment for urinary incontinence: never, now or in the future? JAMA. 1001;293:998.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.